期刊文献+

雷贝拉唑对非糜烂性反流病的疗效研究

Therapeutic Efficacy of Rabeprazole in Non-erosive Reflux Disease
收藏 分享 导出
摘要 目的:研究雷贝拉唑对非靡烂性反流病(NERD)的治疗效果。方法:对98例NERD患者进行临床症状评分、24小时食管pH监测,随机分为两组,A组50例、予雷贝拉唑10mg、日2次、治疗4周,B组48例、予法莫替丁20mg、日2次、治疗4周,观察其对NERD临床症状的改善,24小时食管pH的变化及疗效。结果:经雷贝拉唑治疗4周后,NERD的烧心、反酸、胸痛、反食症状较法莫替丁治疗4周后有明显的改善(P<0.05),24小时食管pH监测显示,pH<4时间百分比、DeMeester评分的变化雷贝拉唑钠组较对照组有显著的差异性(P<0.05),A组治疗NERD的有效率为88%、较B组治疗的有效率62.5%有显著的差异性(P<0.05)。结论:雷贝拉唑钠可显著改善NERD的临床症状,对NERD有较佳的治疗效果,是临床治NERD首选有效的药物。 Objective:To investigate the therapeutic effect of rabeprazole in treatment of non-erosive reflux disease(NERD).Methods:98 cases of patients with NERD were carried out clinical symptoms score,24-hour esophageal pH monitoring and were randomly divided into two groups,50 cases in A group and 48 cases in B group,rabeprazole 10mg Bid and famotidine 20mg Bid were gave respectively for 4 weeks,observe the improvement of NERD clinical symptoms,the change and the therapeutic effect of 24-hour esophageal pH by them....
作者 唐毅 TANG Yi(Digestive Department; Suining People s Hospital; Suining Sichuan 629000; China);
出处 《华西医学》 CAS 2008年第6期共2页 West China Medical Journal
关键词 非靡烂性反流病 雷贝拉唑 24小时食管PH监测 NERD rabeprazole 24-hour esophageal pH monitoring
  • 相关文献

参考文献3

  • 1[1]papa A,urgesi R,Grillo A,et al.Pathophysiology,diagnosis and treatment of non-erosive reflux disease(NERD)[J].Minerva Gastroenterol Dietol,2004,50(3):215-226. 被引量:1
  • 2[3]Kaplan-Machlis B,spiegler GE,Revicki DA.Healthrelated quality of life in primary care patients with gastroesophageal reflux disease.Ann pharmacother,1999,33:1032-1036. 被引量:1
  • 3张林,王江滨.CYP2C19与质子泵抑制剂[J].国外医学:消化系疾病分册,2004,24(3):166-169. 被引量:11

二级参考文献16

  • 1Abelo A, Andersson TB, Antonsson M, et al. Drug Metab Dispos, 2000 ; 28:966 - 972 被引量:1
  • 2Klotz U. Clin Pharmacokinet, 2000; 38 : 243 - 270 被引量:1
  • 3Chang M, Tybring G, Dahl ML, et al. Br J Clin Pharmacol,1995;39:511-518 被引量:1
  • 4Furuta T, Ohashi K, Kosuge K, et al. Clin Pharmacol Ther,1999 ;65 : 552-561 被引量:1
  • 5Sagar M, Bertilsson L, Stridsberg M, et al. Aliment Pharmacol Ther,2000 ; 14: 1495-1502 被引量:1
  • 6Lehmann FS, Hildebrand P,Beglinger C. Drugs,2003;63:1785- 1797 被引量:1
  • 7Sagar M, Janczewska I, Ljungdahl A, et al. Aliment Pharmacol Ther, 1999 ; 13:453-458 被引量:1
  • 8Howden CW. J Clin Gastroenterol,2000;30:29-33 被引量:1
  • 9Furuta T,Ohashi K, Kamata T,et al. Ann Intern Med,1998;129:1027- 1030L 被引量:1
  • 10Aoyama N,Tanigawara Y,Kita T,et al. J Gastroenterol,1999;34 : 80- 83 被引量:1

共引文献10

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈